DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, giving promising advancements across several healthcare and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, much more responsible alternative for therapeutic use, notab